www.nature.com/scientificreports

OPEN Defining Clonal Color in Fluorescent Multi-Clonal Tracking

received: 27 August 2015 accepted: 08 March 2016
Published: 13 April 2016

Juwell W. Wu1,2, Raphaël Turcotte1,2, Clemens Alt1,2, Judith M. Runnels1,2, Hensin Tsao3,4,5 & Charles P. Lin1,2,6
Clonal heterogeneity and selection underpin many biological processes including development and tumor progression. Combinatorial fluorescent protein expression in germline cells has proven its utility for tracking the formation and regeneration of different organ systems. Such cell populations encoded by combinatorial fluorescent proteins are also attractive tools for understanding clonal expansion and clonal competition in cancer. However, the assignment of clonal identity requires an analytical framework in which clonal markings can be parameterized and validated. Here we present a systematic and quantitative method for RGB analysis of fluorescent melanoma cancer clones. We then demonstrate refined clonal trackability of melanoma cells using this scheme.

Long-term and non-destructive tracking of live cells has been made possible with fluorescence imaging and endogenous cell labeling with fluorescent proteins (FP). Development of engineered animal models expressing combinatorial copies of stochastically chosen fluorescent protein reporters, most notably the “Brainbow” mouse1,2 and its successors, has permitted fluorescent cell and clonal tracking in vivo and ex vivo with their ability to distinctively color-code multiple cells and clones. Real-time observation of clonal interactions at single cell resolution informs on clonal dominance, extinction and changes in spatial resolution and has offered invaluable insight to developmental, regenerative and cancer biology3–31.
Rapid expansion in FPs’ spectral repertoire, improvements in their photochemical properties and tolerated expression levels have created a rich palette for simultaneous tracking of multiple cells and clones. In response to the increasingly crowded color space, cell color descriptors in literature have evolved from broad, colloquial terms dependent on human vision (“purple”) to RGB quantifiers, hue and saturation values1,10,16,23,27,32–35. Nonetheless, clonal identity, as defined by the collective RGB properties of cells in a clone, has yet to be described. Fluorescent clonal tracking operates on clonal RGB descriptor rather than individual cell RGB descriptor. If a cell is represented by a point in the RGB space, a clone is the collection of points that occupy a finite volume in the RGB space. Knowledge of clonal RGB properties is a requisite for matching individual cells to their clonal origin during clonal tracking studies. Sophisticated clustering algorithms, which have seen use for this task of clonal assignment27, must make implicit assumptions on how cell colors are distributed in participant clones. Assignment accuracy of these algorithms is hence limited by the accuracy of these assumptions.
Our goal is to devise a strategy for fluorescent clonal tracking such that each individual cell can be rigorously tracked back to its clonal origin, independent of human vision subjectivity or statistical models, and spatial and morphological attributes of clonal cells. Towards this goal, we will first perform a large scale study of “Rainbow” clones, each with a combinatorial expression of three fluorescent proteins, and define metrics for the clonal RGB properties that most influence the setup and interpretation of fluorescent clonal tracking experiments. We will then describe the criteria for selecting clones suitable for fluorescent clonal tracking using these metrics and construct the quantitative framework for clonal assignment. We will finally demonstrate the efficacy of our method by establishing a human melanoma cell line population with verifiable clonal trackability and report its clonal composition for fifteen weeks. Based on our findings, we will introduce a new strategy that allows robust clonal tracking in live cells, relying solely on fluorophore expression as the clonal marker.

1Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. 2Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. 3Department of Dermatology, Harvard Medical School, Boston, MA 02114, USA. 4Wellman Center for Photomedicine, Harvard Medical School, Boston, MA 02114, USA. 5Massachusetts General Hospital Melanoma and Pigmented Lesion Center, Boston, MA 02114, USA. 6Harvard Stem Cell Institute, Cambridge, Massachusetts 02138, USA. Correspondence and requests for materials should be addressed to H.T. (email: htsao@mgh.harvard.edu) or C.P.L. (email: charles_lin@mgh.harvard.edu)

Scientific Reports | 6:24303 | DOI: 10.1038/srep24303

1

www.nature.com/scientificreports/

Figure 1.  Cell color and the chromaticity grid. (a) RGB cell colors in spherical coordinates. Azimuth Θ  and elevation Φ describe chromaticity. Radius describes brightness, or value. (b) Cells of equal chromaticity, regardless of value, project to the same point on the first octant surface of a sphere, which we defined as the chromaticity grid. (c) 1FP+ and 2FP+ expressions are positioned at the corners and edges of the chromaticity grid, respectively. 3FP+ expressions are positioned on the grid. (d) Representative confocal image of MelaChroma, MOI =  0.7, 32 days after lentiviral transduction. (e) Spherical scatter plot of (d). Each data point, at chromaticity coordinate (Θ , Φ ), designates the chromaticity value of a cell (2.6E5 total, analyzed by flow cytometry). (f) Spherical histogram of (d). Each grid element (Θ  =  0.2° ×  Φ  =  0.2°) displays the adjusted cell count “binned” to the element (Supplementary Fig. S1). (g) Representative confocal image of MelaChroma, MOI =  4.9, 32 days after lentiviral transduction. (h) Spherical scatter plot of (g). 2.6E5 cells were analyzed. (i) Spherical histogram of (g). Compared to (f), this higher MOI population was enriched in 3FP-expressing cells. Scale bar: 25 μm.

Results

Defining the color space.  Color descriptions, whether of cells or clones, are only meaningful when refer-

enced to a well-defined, consistent color space. The color space must also accommodate all cell colors that may be

presented. For ease of communication, “colors” in this manuscript will from here on refer to RGB combinations.

First, we developed a system for quantifying cell colors that separates the ratio versus the amplitude of fluores-

cence intensity signal in Red, Green and Blue. Contributors of fluorescence include both the fluorescent proteins

and autofluorescence. We converted the 3D Cartesian RGB fluorescent signal intensities into spherical coordi-

nates and defined chromaticity, in azimuth Θ and elevation Φ , as the value-normalized color (Fig. 1a). Cells with

the our

same R:G:B intensity signal ratio chromaticity grid, which is easily

in the color space project to the same visualized with the surface of the first

ochctraonmt aotficaistyphceoroer(dFiniga.t 1eb(,Θc) 0.,

Φ 0)

on

Maximum color diversity is achieved when the full range of intracellular concentrations of FPs well tolerated

by cells are present in a cell population. To determine the widest, viable range of FP concentrations, we performed

the RGB cell marking scheme using lentiviral gene ontology (LeGO) vectors developed by Weber et al.36–38 on

five A375 human amelanotic melanoma cell line populations. We transduced each population with three LeGO

lentiviral particle constructs carrying the genetic code of Cerulean39 (CFP variant, assigned to Blue), Venus40

Scientific Reports | 6:24303 | DOI: 10.1038/srep24303

2

www.nature.com/scientificreports/

(YFP variant, Green) and tdTomato41 (RFP variant, Red) at equal dosages of multiplicity of infection (MOI) 0.7, 1.4, 2.8, 4.9, and 7.0 respectively. We named these cell populations MelaChroma for their visually colorful palette (Fig. 1d,g).
We introduced spherical scatter plots (Fig. 1e,h) and histograms (Fig. 1f,i, Supplementary Fig. S1) to display chromaticity information for both monoclonal populations and multi-clonal populations such as the MelaChromas. Cells fluorescing in one of the three primary chromaticities (red, green, blue), i.e., those expressing a single FP (1FP+ ), congregate at the corners of these plots. Cells expressing any combination of two FPs (2FP+ ) fluoresce in two of the three primary chromaticities (red+ green, green+ blue, blue+ red) and congregate along the edges. Cells expressing all three FPs (3FP+ ) spread over the plots’ surface. Spherical scatter plots and histograms of the MelaChomas revealed a balanced presence of blue, green and red FPs and improved chromatic diversity at higher MOIs, the latter evidenced by the filling of the surface of the chromaticity grid that signified increased percentage of 3FP+ cells (Fig. 1d–i, Supplementary Fig. S2). Such enhancement in chromatic diversity, predicted by Poisson statistics38,42, nonetheless diminished by MOI 7.0, which also showed no improvement in fluorescent signal intensities compared to MOI 4.9 (data not shown). Higher lentiviral dosages were not pursued.
Next, we established and fixed the acquisition parameters (such as laser excitation power and detector gain) for all systems to be used for clonal tracking with the same cell populations. We imaged and performed flow cytometry on the five MelaChroma populations, which would supply the clonal founder cells. Following the previous recommendations for “Brainbow” imaging14,31, the settings of our fluorescence confocal microscope and flow cytometer were adjusted such that each detection channel, in each imaging system, spanned the available intensity scale with minimal saturation (0 to 65535 (16-bit) for fluorescence microscope, 0 to 1E5 for flow cytometer). Cell colors in confocal images therefore matched the colors reported by flow cytometry (Fig. 1d,e,g,h, Supplementary Fig. S3). We also kept these imaging system settings constant throughout the study to obtain consistent color reporting over time.

Generating clonal populations.  We devised a strategy to isolate chromatically diverse founder cells for clonal expansion. Our goal was to build a library of diversely color-coded clones with representative clonal color properties, which would also serve as potential participant clones in a multi-clone tracking study. In vitro cultures of individual clones and flow cytometry allow repeatable clonal color data collection at high cell counts per clone. We used MelaChroma cells of MOIs 0.7, 2.8 and 4.9 as our source of founder cells. These MelaChromas had different distributions of intracellular FP concentrations, corresponding to different RGB intensities. To avoid oversampling of high frequency chromaticities in each MelaChroma, we created a combinatorial FACS gating scheme for founder cell sorting that further ensured selection of cells with diverse RGB ratios (Fig. 2a,b).

Defining metrics for characterizing clonal colors.  In an ideal clonally trackable population, each cell

can be unambiguously assigned to one of the pre-determined list of participating clones. This requires the follow-

ing color criteria to be met16,27,33: 1) the color of each participant clone is distinguishable from other participant

clones’; 2) minimal contribution of autofluorescence to the color code, in this case by the fluorescent proteins; and

3) the color of each participant clone is stable for the duration of the clonal tracking experiment.

Based on these criteria, we defined four metrics for clonal color: chromatic mode, chromatic spread, relative

clonal brightness and chromatic stability. Chromatic mode and spread measure the chromaticity center of a clonal

population and the span of its chromaticity distribution. Relative clonal brightness measures the relative contri-

bution of fluorescent proteins against autofluorescence towards total clonal fluorescence intensity. Chromatic

stability measures clonal chromatic shifts over time. Robust relative clonal brightness and chromatic stability

qualifies individual clones as candidates for long term clonal tracking. Chromatic mode and chromatic spread

then limits the number of qualified clones that are distinguishable and can participate in a clonal tracking study

(Supplementary Fig. S4).

We then provided analytical definitions for our metrics, in the context of our color space and chromaticity

grid. We designated a clone’s chromatic mode as the chromatic We quantified the chromatic spread as the area confined within isosurface (Fig. 2c,d, Supplementary Fig. S5).

cthoeorcdhirnoamteawticitihtytghreidhipgrhoejsetcctiloonnaolfcferlalcctoiounnatlnnmmaaxx.

Our relative clonal brightness metric reports the percentage of clonal cells with FP-to-autofluorescence

contribution to total cellular fluorescence surpassing a benchmark value b*. We analyzed the autofluorescence

(AF) of un-transduced A375 cells and showed that it behaved like clonal colors with characteristic chromatic

mode, chromatic spread and value (Supplementary Fig. S5). Cells with diminishing FP-to-AF contribution chro-

matically skew towards the chromatic mode of autofluorescence. Consequently, clones with subpopulations of

these “dim” cells could suffer from very large chromatic spreads. As AF was used as reference for comparing

FP fluorescence contribution, our measurement of relative clonal brightness began with the definition of one

autofluorescence unit, or 1 xAF (Multiple of Autofluorescence), with the 2% isosurface chromatic spread of the

un-transduced A375 population. We then defined the relative brightness of individual cells, regardless of clonal

origin, as b multiples of 1 xAF; autofluorescence contribution to the cell’s total fluorescence is expected to be < 1/b

(Supplementary Fig. S5). Relative clonal brightness was subsequently defined as the fraction of clonal cells that

surpass a sufficiently high b* value at which autofluorescence no longer influence clonal chromatic spreads. Ideal

relative clonal brightness is one.

We measured chromatic stability by quantifying the change in clones’ chromatic spread over time

(Supplementary Fig. S6). Conceptually, our calculation for chromatic stability reports the additional area covered

by a clone’s chromatic spread per time point measurement with respect to the clone’s smallest single-time-point

chromatic spread area. The unitless outcome is hence insensitive to the size of the chromatic spread, which allows

inter-clonal comparison. Ideal chromatic stability is zero, meaning there is no gain in chromatic spread areal

coverage.

Scientific Reports | 6:24303 | DOI: 10.1038/srep24303

3

www.nature.com/scientificreports/

Figure 2.  Clonal founder cell selection, clonal chromatic mode and chromatic spread. (a) Combinatorial gating scheme for single clonal founder cell sorting. RGB channels were gated by intensity and different combinations of these R/G/B channel gates were used to select single cells from MelaChromas for clonal expansion. MelaChromas of various MOIs (0.7, 2.8, 4.9) were used the source of founder cells. As a result, a wide variety of FP expression levels and Cerulean(B):Venus(G):tdTomato(R) ratios were represented in the selected cells, as shown in the confocal images of expanded clones. For visual reference, confocal images of 1FPexpressing clones and un-transduced A375 cells (A375-WT) at 50% magnification are also shown. Scale bar: 25 μm. (b) Spherical scatter plots of the clones in (a). 1E4 cells were analyzed by flow cytometry per clone. (c) Spherical histogram of clone #2 in (a,b). (d) Chromatic mode (crosshair) and chromatic spreads (pink) of clone #2. Chromatic spreads, as projections of isosurfaces drawn at 50%, 25%, 10%, 5%, 2%, and 1% of the highest cell count at the chromatic mode (Supplementary Fig. S4), co-localized with the high cell count region in the clonal spherical histogram (same as (c), shown magnified in white). Values indicate the actual percentage of clonal cells with chromaticity values enclosed within each contour. (e), Spherical scatter plot showing the chromatic mode coordinates of the 256 expanded MelaChroma clones.

We then applied the four clonal color metrics to characterize our 256 expanded MelaChroma clones. We confirmed our collection of clones was chromatically representative of the full chromaticity grid by plotting the clones’ chromatic modes (Fig. 2e). However, we observed non-uniformity in the clones’ chromatic spread and chromatic stability, which followed a roughly Gaussian distribution with a small but significant number of poorly performing outliers but no chromaticity dependence (Supplementary Fig. S7). Relative brightness of cells within a clone typically followed a skewed xAF distribution that is cell cycle status dependent (Supplementary Fig. S8); clones with inferior relative clonal brightness congregated near the blue corner of the chromaticity grid (Supplementary Fig. S7). Selecting chromatically distinguishable clones; creating clonally trackable MelaChroma and clonal assignment.  Accuracy of clonal assignment is inversely related to the amount of overlap between chromatic spreads of participant clones. Accuracy is guaranteed when there is no overlap, but at the cost of fewer clones being able to participate. We therefore opted to examine a more realistic scenario in which minor overlaps of chromaticity spread are allowed and devised a method to estimate the assignment error associated with such overlaps.
Our scheme for clonal assignment was to match the chromaticity coordinate of each cell of unknown clonal origin to the known set of chromaticity coordinates bounded by each participant clone’s chromatic spreads. We constructed the matching template, or chromatic landscape that described the chromatic mode (“peaks”) and chromatic spreads (“altitudes” in cell count) of all participant clones, using computational analysis of the clonal color data collected from the previous section. First, we finalized our candidate clonal pool by admitting only MelaChroma clones that met the criteria of non-outlying chromatic stability and 97.5 percentile for relative clonal brightness, with b* set at 20. Higher b* values improve clonal identification accuracy but admit fewer clones into the pool (Supplementary Fig. S9).
Next, we digitally pooled the color data of different subsets of clones from this candidate pool to determine a subset for actual mixing, with inter-clonal distinguishability based on their chromatic mode and chromatic spreads (Fig. 3a). Our elected subset of fifteen clones exhibited non-overlapping chromatic mode and 50% isosurface chromatic spread and we named the resulting multi-clonal population ct-MelaChroma for its clonal

Scientific Reports | 6:24303 | DOI: 10.1038/srep24303

4

www.nature.com/scientificreports/

Figure 3.  Generating clonally trackable MelaChroma and clonal assignment. (a) Digitally pooled color data of a 15-clone subset selected from the MelaChroma candidate clonal pool. These fifteen clones had nonoverlapping chromatic modes and 50% isosurface chromatic spreads. Color data of 9E4 cells represented each clone. Spherical scatter plot of the pooled color data is shown. (b) Spherical scatter plot of the cell population generated by physically pooling the fifteen clones in (a). We named this population ct-MelaChroma for its clonal trackability. 1.35E6 cells were analyzed by flow cytometry two days after clonal pooling. (c) Chromatic landscape of ct-MelaChroma. Chromatic modes and chromatic spreads of the fifteen clones were positioned on this landscape by the digital pooling of clonal color data (a). Clonal assignment rules for chromaticity grid elements mapped to multiple clones were subsequently applied (Supplementary Fig. S10). Confocal images exemplify clones that were difficult to distinguish by eye but readily distinguishable by chromaticity plotting (scale bar: 25 μm). (d) Spherical histogram of ct-MelaChroma eight days post clonal pooling. ct-MelaChroma’s flow cytometry data carried no information of each cell’s clonal identity. 1.53E6 cells were analyzed by flow cytometry. (e) Our clonal assignment algorithm numerically matched the chromaticity coordinate of each ct-MelaChroma cell to the chromaticity coordinates bounded by each clone in the chromatic landscape. An overlay of (d,c) illustrates this concept. Correction of non-ideal chromatic stability had been performed (Supplementary Fig. S11). (f) ct-MelaChroma’s clonal composition is the output of the clonal assignment algorithm. Cells in the spherical histogram (d) were color-coded according to their assigned clone. Numerical frequency of each participant clone was listed. “U” (unassigned) designated cells with out-of-bounds chromaticity coordinate in the chromatic landscape or cells that could not be exclusively assigned to one clone (“yellow” region, Supplementary Fig. S10).

trackability. Chromaticity plot of the physically pooled fifteen clones of ct-MelaChroma (Fig. 3b) agreed well with

its digitally pooled model.

Our chromatic landscape also served as an efficient visual and computational framework for addressing

the uncertainty of assignment for (Θ , Φ ) chromaticity coordinates mapped to multiple clones (Supplementary

Fig. S10). We reasoned that given the % isosurface of overlapping chromatic spreads at a chromaticity coordi-

nbeataes(sΘig 0n,eΦd 0t)odoensceriobfeththeecrloelnaetisv,ethoecncutphaetrioelnatpivroeboacbciuliptyatoiof nthpercoobrarbeislpitoynmdiunsgt

clones, if a cell at also describe the

(pΘro 0,bΦab 0i)limtyuostf

accurate clonal assignment. Application of these clonal assignment rules (Supplementary Fig. S10) created our

finalized ct-MelaChroma’s chromatic landscape, which also confirmed chromaticity measurements as powerful

discriminators of clones that were visually similar in color (Fig. 3c).

To validate the utility of the chromaticity landscape, we performed clonal assignment on each of the fif-

teen participant clones of ct-MelaChroma. As each cell’s clonal origin was known, we were able to confirm that

> 86% cells in each clone were correctly assigned. We were also able to determine the percentage of cells in each

clone that were “Unassigned” based on our clonal assignment rules and that were assigned to a wrong clone.

aiRtniscesgi-ipgacarnlonrmantnaecglnloeatnmseseriesrgn’onctrmhorrafeonntmghteeaasocteicfcu[rp0erars.4ouc5yplt%es(rS,ctu7ire.pe1sap1.tl%Meedm]s.terheneptaosrprytislFlotihgve.eSrr1em0la)at.tiMvriexsofMoccrsu,cpstp-aMeticoeinlfaicCptrhoorbocamlobnailaiptlireaessdsaiicngtndedmisaeuncslteordnuefl-oedsrecapaneldcnudpleaanrt--t

Scientific Reports | 6:24303 | DOI: 10.1038/srep24303

5

www.nature.com/scientificreports/

Figure 4.  ct-MelaChroma’s clonal composition over time. (a) Mean frequency of participant clones of ctMelaChroma on various days post pooling. Emergence dominance of three clones (01, 02, 03) was evident by Day 8. (b) Clonal composition of ct-MelaChroma over the course of fifteen weeks. The 12% clonal frequency cutoff at Week 2 separated the clones that trended towards dominance (clones 01–3) versus withdrawal (clones 04–15). Error bars denote standard deviations of the six samples analyzed by flow cytometry for the day except for Days 51 and 72, on which two samples were analyzed. 1.35–2.32E6 cells were clonally assigned, per sample, on all days. (c) Mono-clonal growth curves of five of ct-MelaChroma’s participant clones. WT denotes untransduced A375 cells. Four measurements were made per time point between two consecutive sub-cultures. Error bars indicate standard errors for each measurement.

Long-term clonal tracking of clonally trackable MelaChroma.  To examine the long-term efficacy

of ct-MelaChroma, we observed the clonal composition of ct-MelaChroma’s for fifteen weeks. Two days after

ct-MelaChroma pooling, we distributed the cells into six independent samples and determined the participant

clonal frequencies in each sample over time.

We developed an algorithm for automatic clonal assignment of ct-MelaChroma cells (Fig. 3d,e). Chromaticity

mismatches due to non-ideal clonal chromatic stability were corrected prior to clonal assignment (Supplementary

Fig. S11). The algorithm’s output was ct-MelaChroma’s clonal composition, a list of frequencies of the fifteen par-

ticipant clones (Fig. 3f). Clones at < 5% frequency can be recovered by this algorithm even when the chromatic

landscape Clonal

ifsreinqucoemncpielestsehaonwdeMd ssmreamllasitnasnudnarddefdineveidat(iSounpspbleetmweenetnarthyeFsiigx.

S12). ct-MelaChroma

samples,

particularly

at

early time points. Divergence of ct-MelaChroma’s participant clonal frequencies from their initial, matching val-

ues (100/15 =  6.67%) occurred early and quickly (Fig. 4a,b). Three dominant clones emerged (01, 02, 03), roughly

doubling in clonal frequency in the first two weeks, while other clones (04–15) trended towards withdrawal.

Notably, the most dominant clone (01) in the first half of the study exhibited frequency decline beyond Week 9.

To determine if the observed pattern of clonal evolution is simply a reflection of individual clonal growth rate, we

measured the growth of five participant clones in mono-clonal cultures (Fig. 4c). Interestingly, the fastest growing

clone (04) was a withdrawing clone in ct-MelaChroma and its growth rate surpassed that of ct-MelaChroma’s

dominant clone 01.

Discussion
We presented a method for performing fluorescent clonal tracking by characterizing clonal colors from triple fluorescent protein expression. By using an in vitro cell line, we were able to identify with certainty the progenies of individual clonal founder cells and perform large-scale sampling that allowed us to define proper metrics for clonal colors. These metrics streamlined the collection of a priori clonal color information, cumulating to the

Scientific Reports | 6:24303 | DOI: 10.1038/srep24303

6

www.nature.com/scientificreports/

construction of a deterministic clonal assignment scheme for multi-clonal tracking. We were thus able to generate

a multi-clonal population with chromaticity distinguishable clones, validate its clonal trackability, and report its

clonal composition over time with known accuracy.

We observed a remarkably consistent pattern of clonal evolution among the six duplicates of our fifteen-clone

ct-MelaChroma population. Clonal frequencies over the fifteen weeks showed small sample-to-sample devia-

tions, with the same subsets of participant clones trending towards dominance and withdrawal. While variations

in participant clonal growth rates could explain the outcome, our data (Fig. 4c) suggested additional driving

forces related to the complex clonal interactions in the tumor microenvironment. These driving forces may be

related to interclonal Darwinian selection pressures, as recently summarized by Tabassum and Polyak43.

Fluorescent clonal tracking operates on clonal color. Clonal color codes are identified not by the color of a cell,

but the color of the ensemble of cells belonging to a clone. Our study highlights the importance of independent

verification of clonal diversity when fluorescence color is utilized as a clonal identifier: cell color diversity, when

observed in a multi-clonal population, infers clonal diversity only when certain properties about clonal color

are known. We described these properties in four metrics: chromatic mode, chromatic spread, relative clonal

brightness and chromatic stability. These metrics quantify the criteria for building a clonally trackable popula-

tion: clonal inter-distinguishability, minimal autofluorescence contribution to clonal fluorescence and stability of

clonal color over time.

A database of clonal color properties based on the four metrics provides a platform for creating multiple clon-

ally trackable populations from the same candidate pool, perform reliable in vitro fluorescence clonal tracking

with each at known accuracy. Similar databases as our MelaChroma database can provide insights to the expected

clonal diversity in in vivo “Brainbow”-like systems for which such database is difficult to construct; for example,

plasmids of various versions of the Brainbow construct are available for in vitro testing. Our clonal assignment

algorithm also facilitates the transfer of our strategy to in vivo “Brainbow”-like system; we demonstrated that,

even with incomplete chromatic ble to those from FACS analysis.

landscapes and While we were

uconnksniostwenntMwsi,ththoeuarlgcohroitichemorfeFpPosratsncdlothneailrfreexqpureenssciioens

comparapromoter

(SFFV) in this study, we recognized that they are significant determinants of clonal color properties. Clones with

inferior relative clonal brightness were mostly “blue” due to the relatively low (extinction coefficient ×  quantum

ypwirheelisdce)hnoccfeaCnoferriemunlmdeaeanrtucclrooemnflpaulaorcreoedlsoctroesnVpteHsnpuescseinaenssidttihvtadetTwhoahmveeantbope4Ke4,n4a5;rveoaptluhoeersrteFadrPefopdrrioRspsFiemPrsti4ile6a.srDabfifefeftecwrteiennegcneceslxoinpnraienlsctseoignlorgartFiinoPncsl,usaidtneedspctKahnae,

explain the inter-clonal variations in chromatic spread and chromatic stability. We noted that chromatic insta-

bility did not, in most cases, correspond to the silencing of a FP marker, which could be identified by monotonic

decrease in fluorescent intensities over time and chromaticity mode shift towards autofluorescence (data not

shown).

Diversity of clonal color codes is necessary for fluorescent clonal tracking. We expanded our yield of distin-

guishable clonal colors in our candidate clonal pool during the generation of MelaChromas, from which our

clonal founder cells would be drawn. We learned that there was an optimal dosage for generating the most color

diverse MelaChromas and higher dosages did not yield more colors. We propose that toxicity of FPs at high

expression levels was likely cause of reduced color diversity at high lentiviral transduction dosages and should

be taken into consideration whenever color generation by combinatorial FP expression is implemented. Also,

we developed a combinatorial gating scheme for single clonal founder cell selection that reduced the number of

clones required to capture the available clonal colors, including those present in low frequencies, in the candi-

date clonal pool. While our clonal founder gating scheme was designed for in vitro use, its underlying principle

extends to in vivo and ex vivo scenarios in which the spatial location of cells are used as clonal co-identifier,

namely when cells of similar colors and in close proximity are assumed to share a common clonal origin. This

assumption not only requires local presence of clonal founders in diverse color codes, but also that they are pres-

ent at similar frequencies. The ability to verify the presence of diverse color codes once again requires knowledge

of clonal colors, especially their size relative to the size of the color space.

We chose ct-MelaChroma’s fifteen participant clones exclusively from our candidate pool of 150 3FP+  clones.

We can increase the number of trackable clones by including 1FP+ and 2FP+ clones. We can also introduce

new clones to our pool. Relaxing the candidate clonal pool’s selection criteria (inclusion of outliers for chromatic

stability, lowering b* and the 97.5% percentile cutoff for relative clonal brightness) would also increase the size

of the pool but at the cost of clonal assignment accuracy. Maximal numbers of participant clones is achieved via

full chromaticity grid coverage with bright, chromatically stable clones of small chromatic spreads. Full coverage

of the chromaticity grid requires a color diverse clonal source, as we have demonstrated with MelaChromas.

Improvements in the fluorophores’ photophysical properties, incorporation and detection methods will lead to

smaller clonal chromatic spreads.

In summary, we have demonstrated a strategy for creating RGB-coded, multi-clonal populations that is

extendable with advancements in imaging technology, fluorophore design, and labeling technology including

genetic engineering. Our strategy, which allows rigorous and objective clonal identification of each cell by its

RGB color-coding, is as follows: 1) create a diversely color-coded, multi-clonal population and establish a con-

sistent color space that accommodates all RGB color codes; 2) in the established color space, triage individual

clones suitable for clonal tracking by relative clonal brightness and chromatic stability; and 3) identify subsets

of chromatically distinguishable clones for physical pooling based on clonal chromatic mode and spread. RGB

color-codes can originate from the combinatorial expression of any long-term endogenous or exogenous cell

labeling fluorophores. R, G, B intensity information can be collected from different imaging modalities. With

sufficient computational power, our algorithms can accommodate large numbers of participant clones. Our

clonal color metrics will also lay the foundation for building mathematical models that truly mimic clonal color

behavior. We will be able to, for example, generate statistically robust functions describing the chromatic mode

Scientific Reports | 6:24303 | DOI: 10.1038/srep24303

7

www.nature.com/scientificreports/

and chromatic spread for each candidate clone, which will streamline intra- and inter-clonal comparisons and facilitate the implementation of complex clonal assignment rules, cumulating to high assignment accuracy. Of note, our methods of clonal color and clonal composition analysis are not restricted to three-fluorophore systems. It can be expanded into n-dimension space with each dimension representing a fluorophore. Our strategy is also compatible with alternate clonal assignment methods. Mathematical models of clonal color behavior can be applied for clustering analysis. While our strategy does not require spatial location or morphological information, inclusion of additional spatial/morphological information will reduce the uncertainties and errors associated with color-based clonal assignment. Meanwhile, our strategy retains the ability to assign in sparsely-populated or highly dynamic environments, such as those in minimal residual disease setting. Integration of different clonal assignment methods shall lead to highly accurate and efficient multi-clonal tracking studies.

Methods Production and titer calculation for LeGO lentivirus.  Lentiviral Gene Ontology (LeGO) vectors
LeGO-Cer2, LeGO-V2 and LeGO-T2 were generous gifts from Drs. Kristoffer Riecken (né Weber) and Boris Fehse at the University Medical Center Hamburg-Eppendorf. Plasmid replications were performed via transformation of NEB 5-alpha competent E. Coli (New England Biolabs, Ipswich, MA) and DNA purification with the QIAfilter Plasmid Midi Kit (Qiagen, Valencia, CA), according to manufacturer’s instructions.
Lentivirus generation and titer calculation followed previously published protocol38, scaled up 2.75× . Briefly, 1.375E7 HEK-293T cells were seeded in a T175 flask for an 8-hour transfection, for which 27.5 μg LeGO (Cer2, V2 or T2), 27.5 μg pMDLg/RRE, 13.75 μg rPSV-Rev and 5.50 μg pHCMV-VSV-G plasmids were added. Cells were subsequently filter-removed with 100 μm nylon mesh cell strainer and 0.45 μm PVDF syringe filters. For titer determination, HEK-293 T cells were seeded in 24-well plates at 5E4 cells per well, and transduced for 13 hours with 0.1, 0.5, 1.0, 5.0, 10.0, or 100 μL of viral supernatant. Three wells were transduced per supernatant volume. Percent fluorescent cells were determined three days later with flow cytometry. Calcium phosphate transfection kit was purchased from Sigma-Aldrich.

Melanoma Cell Line.  A375 human amelanotic melanoma cell line (ATCC) was cultured in phenol-red free

DMEM supplemented with 10% fetal bovine serum, 2.6 g/L sodium bicarbonate, 3.5 g/L glucose (for 4.5 g/L total

concentration) and 50 U/mL Cellstripper (non-enzymatic

penicillin-streptomycin, cell dissociation solution;

and incubated in 37 °C, Corning Inc.) was used

f5o%r cCelOl h2 ahruvmesitdsi.fied

atmosphere.

Generation of fluorescent protein expressing, multi-clonal human melanoma (MelaChroma).  Multi-clonal A375 populations expressing diverse fluorescent colors were named “MelaChromas”. MelaChomas, along with A375-Cerulean, A375-Venus and A375-tdTomato, were generated with minor modifications from previously published protocol38. A375 cells were seeded in 6-well plates, at 5E4 cells in 2.4 mL culture media per well. Two hours later, 8 μg/mL polybrene was introduced with lentiviral particles carrying LeGO-Cer2, LeGO-V2 and/ or LeGO-T2, at dosages measured in multiplicity of infection (MOI). Six MOIs (0.35, 0.70, 1.4, 2.8, 4.9, and 7.0) were tested, two wells per MOI. MelaChromas were given all three lentiviruses at equal MOIs. A375-Cerulean, A375-Venus and A375-tdTomato were transduced, respectively, with only LeGO-Cer2, LeGO-V2 or LeGO-T2, each at the same MOIs given to MelaChromas. Cells were subsequently incubated for 16 hours, after which transduction was terminated by culture media change. Three days later, fluorescent protein expression was determined for each A375 population by flow cytometry.

Creation and maintenance of 3FP- and 1FP- expressing MelaChroma clones.  On Day 5 and Day 10 after MelaChroma generation, single cells were sorted into 24-well plates by FACS using a combinatorial RGB intensity gating scheme. Each well was pre-filled with 0.4 mL culture media supplemented with 25 mM HEPES. MelaChromas of MOI =  0.7, 2.8 and 4.9 were used as cell sources. For each MelaChroma, R/G/B channel gain settings were adjusted such that its fluorescence signals spanned the full intensity range of 0–65536 (16-bit) for fluorescence microscopy and 0–1E5 for flow cytometry. A total of 504 cells that expressed three FPs were plated for clonal expansion.
Wells were inspected weekly with a light microscope. Once a clone exhibited three dimensional growth, its cells were harvested and re-plated without sub-culturing. Maintenance of the clone then followed the protocol for A375 cell line.
A375-1FP clonal founder cells were similarly isolated from A375-Cerulean, A375-Venus and A375 tdTomato (MOI =  7.0) and expanded, on Day 32 after generation of the source populations.

Clonally trackable MelaChroma generation and maintenance.  Clonally trackable (ct)-MelaChroma was generated by mixing 1.2E6 cells from fifteen different clones. The cells (1.8E7 total) were incubated for 36 hours, harvested and seeded into six T75 flasks, at 2E6 cells each. Afterwards, the six flasks were sub-cultured at 1:8 twice every week, on identical schedules. Flow cytometry was performed on days of sub-culturing.

Flow cytometry and confocal imaging.  Flow cytometry was performed by the FACSAria installed with FACSDiva software (BD Biosciences). Cerulean fluorescent protein was excited at 405 nm and detected with a 475/20 bandpass filter. Venus was excited at 488 nm and detected with a 528/20 bandpass filter. tdTomato was excited at 561 nm and detected with a 582/15 bandpass filter. All optics settings, including voltage gains for R/G/B detection channels, were finalized on Day 26 after MelaChroma generation. Cells were harvested and re-suspended at 1–2E6 cells/mL DMEM (same formulation as culture media) supplemented with 1% FBS and 25 mM HEPES. A375-wild type (WT) autofluorescence was measured on all days of experiments.
For flow cytometric analysis of cell cycle, MelaChroma clones were pre-labeled with Vybrant DyeCycle Ruby stain (Invitrogen) according to manufacturer’s instructions. The dye was excited at 633 nm and detected with

Scientific Reports | 6:24303 | DOI: 10.1038/srep24303

8

www.nature.com/scientificreports/
a 660/20 bandpass filter. “Spiked” clonal cells were pre-labeled with DRAQ5 (Abcam) according to manufacturer’s instructions. The dye was excited at 633 nm and detected with a 695/40 bandpass filter. Cerulean, Venus and tdTomato channel settings remained as above; fluorescence compensation was not necessary due to spectral separation.
Confocal imaging was performed on the Olympus FluoView FV1000 confocal microscope. Cerulean was excited with 458 nm argon laser line and detected between 475–495 nm. Venus was excited with 515 nm argon laser line and detected between 530–550 nm. tdTomato was excited with 559 nm laser diode and detected between 575–595 nm. 20× , 0.95 NA water immersion objective was used. Voltage gains were finalized on Day 32 after MelaChroma generation. Cells were pre-plated in Lab-Tek chambered cover glass (Thermo Scientific Nunc) or FluoroDish (WPI Inc.) for imaging. DMEM (same formulation as culture media) supplemented with 1% FBS and 25 mM HEPES was used as imaging media. Color data analysis.  Raw RGB color data of singlet cells from flow cytometry were extracted using the software FlowJo (version 7.6; Tree Star) and imported by MATLAB (version 2011b; MathWorks) scripts created in-house for color analysis. MATLAB scripts for color analysis are available online at https://github.com/juwellwwu/ClnColorAnalysis.gitwith instructions and test datasets. Image registration was performed in the image processing software Fiji (ImageJA 1.45b) with the plugin bUnwarpJ downloadable at http://biocomp.cnb.csic. es//~iarganda/bUnwarpJ/47.
References
1.	 Livet, J. et al. Transgenic strategies for combinatorial expression of fluorescent proteins in the nervous system. Nature 450, 56–62 (2007).
2.	 Lichtman, J. W., Livet, J. & Sanes, J. R. A technicolour approach to the connectome. Nat Rev Neurosci 9, 417–422 (2008). 3.	 Red-Horse, K., Ueno, H., Weissman, I. L. & Krasnow, M. A. Coronary arteries form by developmental reprogramming of venous
cells. Nature 464, 549–553 (2010). 4.	 Snippert, H. J. et al. Intestinal Crypt Homeostasis Results from Neutral Competition between Symmetrically Dividing Lgr5 Stem
Cells. Cell 143, 134–144 (2010). 5.	 Hadjieconomou, D. et al. Flybow: genetic multicolor cell labeling for neural circuit analysis in Drosophila melanogaster. Nat
Methods 8, 260–266 (2011). 6.	 Hampel, S. et al. Drosophila Brainbow: a recombinase-based fluorescence labeling technique to subdivide neural expression
patterns. Nat Methods 8, 253–259 (2011). 7.	 Rinkevich, Y., Lindau, P., Ueno, H., Longaker, M. T. & Weissman, I. L. Germ-layer and lineage-restricted stem/progenitors
regenerate the mouse digit tip. Nature 476, 409–413 (2011). 8.	 Wachsman, G., Heidstra, R. & Scheres, B. Distinct Cell-Autonomous Functions of RETINOBLASTOMA-RELATED in Arabidopsis
Stem Cells Revealed by the Brother of Brainbow Clonal Analysis System. The Plant Cell 23, 2581–2591 (2011). 9.	 Forster, D. & Luschnig, S. Src42A-dependent polarized cell shape changes mediate epithelial tube elongation in Drosophila. Nat Cell
Biol 14, 526–534 (2012). 10.	 Gupta, V. & Poss, K. D. Clonally dominant cardiomyocytes direct heart morphogenesis. Nature 484, 479–484 (2012). 11.	 Schepers, A. G. et al. Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science 337, 730–735 (2012). 12.	 Zhang, H. et al. Experimental evidence showing that no mitotically active female germline progenitors exist in postnatal mouse
ovaries. Proc Natl Acad Sci USA 109, 12580–12585 (2012). 13.	 Boulina, M., Samarajeewa, H., Baker, J. D., Kim, M. D. & Chiba, A. Live imaging of multicolor-labeled cells in Drosophila.
Development 140, 1605–1613 (2013). 14.	 Cai, D., Cohen, K. B., Luo, T., Lichtman, J. W. & Sanes, J. R. Improved tools for the Brainbow toolbox. Nat Methods 10, 540–547
(2013). 15.	 Ghigo, C. et al. Multicolor fate mapping of Langerhans cell homeostasis. The Journal of Experimental Medicine 210, 1657–1664
(2013). 16.	 Pan, Y. A. et al. Zebrabow: multispectral cell labeling for cell tracing and lineage analysis in zebrafish. Development 140, 2835–2846
(2013). 17.	 Robles, E., Filosa, A. & Baier, H. Precise Lamination of Retinal Axons Generates Multiple Parallel Input Pathways in the Tectum. The
Journal of Neuroscience 33, 5027–5039 (2013). 18.	 Tabansky, I. et al. Developmental Bias in Cleavage-Stage Mouse Blastomeres. Current Biology 23, 21–31 (2013). 19.	 Tanaka, T. et al. Identification of stem cells that maintain and regenerate lingual keratinized epithelial cells. Nat Cell Biol 15, 511–518
(2013). 20.	 Wang, L. et al. Identification of a clonally expanding haematopoietic compartment in bone marrow. EMBO J 32, 219–230 (2013). 21.	 Worley, M. I., Setiawan, L. & Hariharan, I. K. TIE-DYE: a combinatorial marking system to visualize and genetically manipulate
clones during development in Drosophila melanogaster. Development 140, 3275–3284 (2013). 22.	 Zomer, A. et al. Intravital imaging of cancer stem cell plasticity in mammary tumors. Stem Cells 31, 602–606 (2013). 23.	 Di Girolamo, N. et al. Tracing the fate of limbal epithelial progenitor cells in the murine cornea. Stem Cells 33, 157–169 (2015). 24.	 Dirian, L. et al. Spatial regionalization and heterochrony in the formation of adult pallial neural stem cells. Dev Cell 30, 123–136
(2014). 25.	 Kanca, O., Caussinus, E., Denes, A. S., Percival-Smith, A. & Affolter, M. Raeppli: a whole-tissue labeling tool for live imaging of
Drosophila development. Development 141, 472–480 (2014). 26.	 Komai, Y. et al. Bmi1 expression in long-term germ stem cells. Sci Rep 4, 6175 (2014). 27.	 Loulier, K. et al. Multiplex cell and lineage tracking with combinatorial labels. Neuron 81, 505–520 (2014). 28.	 Rios, A. C., Fu, N. Y., Lindeman, G. J. & Visvader, J. E. In situ identification of bipotent stem cells in the mammary gland. Nature 506,
322–327 (2014). 29.	 Roy, E., Neufeld, Z., Livet, J. & Khosrotehrani, K. Concise review: understanding clonal dynamics in homeostasis and injury through
multicolor lineage tracing. Stem Cells 32, 3046–3054 (2014). 30.	 Amitai-Lange, A. et al. Lineage tracing of stem and progenitor cells of the murine corneal epithelium. Stem Cells 33, 230–239 (2015). 31.	 Weissman, T. A. & Pan, Y. A. Brainbow: New Resources and Emerging Biological Applications for Multicolor Genetic Labeling and
Analysis. Genetics 199, 293–306 (2015). 32.	 Malide, D., Metais, J.-Y. & Dunbar, C. E. Dynamic clonal analysis of murine hematopoietic stem and progenitor cells marked by 5
fluorescent proteins using confocal and multiphoton microscopy. Blood 120, e105–e116 (2012). 33.	 Coffey, S. E., Giedt, R. J. & Weissleder, R. Automated analysis of clonal cancer cells by intravital imaging. IntraVital intravital 2,
e26138 (2013).

Scientific Reports | 6:24303 | DOI: 10.1038/srep24303

9

www.nature.com/scientificreports/
34.	 Garcia-Moreno, F., Vasistha, N. A., Begbie, J. & Molnar, Z. CLoNe is a new method to target single progenitors and study their progeny in mouse and chick. Development 141, 1589–1598 (2014).
35.	 Gomez-Nicola, D., Riecken, K., Fehse, B. & Perry, V. H. In-vivo RGB marking and multicolour single-cell tracking in the adult brain. Sci. Rep. 4, doi: 10.1038/srep07520 (2014).
36.	 Weber, K., Bartsch, U., Stocking, C. & Fehse, B. A Multicolor Panel of Novel Lentiviral “Gene Ontology” (LeGO) Vectors for Functional Gene Analysis. Mol Ther 16, 698–706 (2008).
37.	 Weber, K. et al. RGB marking facilitates multicolor clonal cell tracking. Nat Med 17, 504–509 (2011). 38.	 Weber, K., Thomaschewski, M., Benten, D. & Fehse, B. RGB marking with lentiviral vectors for multicolor clonal cell tracking. Nat.
Protocols 5, 839–849 (2012). 39.	 Rizzo, M. A., Springer, G. H., Granada, B. & Piston, D. W. An improved cyan fluorescent protein variant useful for FRET. Nat Biotech
22, 445–449 (2004). 40.	 Nagai, T. et al. A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat Biotech
20, 87–90 (2002). 41.	 Shaner, N. C. et al. Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent
protein. Nat Biotech 22, 1567–1572 (2004). 42.	 Fehse, B., Kustikova, O. S., Bubenheim, M. & Baum, C. Pois(s)on - It’s a Question of Dose. Gene Ther 11, 879–881 (2004). 43.	 Tabassum, D. P. & Polyak, K. Tumorigenesis: it takes a village. Nat Rev Cancer 15, 473–483 (2015). 44.	 Shaner, N. C. et al. Improving the photostability of bright monomeric orange and red fluorescent proteins. Nat Meth 5, 545–551
(2008). 45.	 Chudakov, D. M., Matz, M. V., Lukyanov, S. & Lukyanov, K. A. Fluorescent Proteins and Their Applications in Imaging Living Cells
and Tissues. Physiological Reviews 90, 1103–1163 (2010). 46.	 Verkhusha, V. V., Chudakov, D. M., Gurskaya, N. G., Lukyanov, S. & Lukyanov, K. A. Common pathway for the red chromophore
formation in fluorescent proteins and chromoproteins. Chem Biol 11, 845–854 (2004). 47.	 Arganda-Carreras, I. et al. In Computer Vision Approaches to Medical Image Analysis 4241 (eds Beichel, R. & Sonka, M.) 85–95
(Springer Berlin Heidelberg, 2006).
Acknowledgements
We thank Dr Kristoffer Riecken (né Weber) and Dr Boris Fehse for kindly providing the LeGO vectors and Dr Sarah Coffey for the VSV-G plasmids. We also thank Dr Tzu-Ming Liu, Jenny Njauw, Dr. Joel Spencer, Dr. Alicia Carlson, and the Wellman Center Photopathology Core for technical assistance. This work is supported by NIH 2P50 CA86355 and K24CA149202.
Author Contributions
J.W.W. designed experiments, conducted research, collected and analysed data and wrote the manuscript. R.T. and C.A. helped write the manuscript and contributed equally. J.M.R. helped perform experiments. H.T. designed experiments, sponsored the project and helped write the manuscript. C.P.L. designed experiments, sponsored the project and wrote the manuscript.
Additional Information
Supplementary information accompanies this paper at http://www.nature.com/srep Competing financial interests: The authors declare no competing financial interests. How to cite this article: Wu, J. W. et al. Defining Clonal Color in Fluorescent Multi-Clonal Tracking. Sci. Rep. 6, 24303; doi: 10.1038/srep24303 (2016).
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Scientific Reports | 6:24303 | DOI: 10.1038/srep24303

10